keyword
MENU ▼
Read by QxMD icon Read
search

Reshma jagsi

keyword
https://www.readbyqxmd.com/read/29760353/direct-and-indirect-harassment-experiences-and-burnout-among-academic-faculty-in-japan
#1
Masumi Takeuchi, Kyoko Nomura, Saki Horie, Hiroko Okinaga, Chithra R Perumalswami, Reshma Jagsi
The purpose of this study is three-fold: (1) to compare harassment (sexual, gender, and academic harassment both directly and indirectly experienced - i.e. "directly harassed" and "have seen or heard of someone who experienced harassment", respectively) experienced by males and females, (2) to investigate whether such experiences correlate with burnout, and (3) to explore whether social support might mitigate any such relationship between harassment and burnout. This cross-sectional study was conducted at a private university in Japan in February 2014 and is based on a work-life balance survey obtained from 330 academic faculty members...
2018: Tohoku Journal of Experimental Medicine
https://www.readbyqxmd.com/read/29718314/simulation-modeling-of-cancer-clinical-trials-application-to-omitting-radiotherapy-in-low-risk-breast-cancer
#2
Jinani Jayasekera, Yisheng Li, Clyde B Schechter, Reshma Jagsi, Juhee Song, Julia White, George Luta, Judith-Anne W Chapman, Eric J Feuer, Richard C Zellars, Natasha Stout, Thomas B Julian, Timothy Whelan, Xuelin Huang, E Shelley Hwang, Judith O Hopkins, Joseph A Sparano, Stewart J Anderson, Anthony W Fyles, Robert Gray, Willi Sauerbrei, Jeanne Mandelblatt, Donald A Berry
Background: We used two models to simulate a proposed noninferiority trial of radiotherapy (RT) omission in low-risk invasive breast cancer to illustrate how modeling could be used to predict the trial's outcomes, inform trial design, and contribute to practice debates. Methods: The proposed trial was a prospective randomized trial of no-RT vs RT in women age 40 to 74 years undergoing lumpectomy and endocrine therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative, stage I breast cancer with an Oncotype DX score of 18 or lower...
April 28, 2018: Journal of the National Cancer Institute
https://www.readbyqxmd.com/read/29695349/quality-of-life-after-multicatheter-breast-brachytherapy
#3
Reshma Jagsi
No abstract text is available yet for this article.
April 20, 2018: Lancet Oncology
https://www.readbyqxmd.com/read/29669187/patient-views-and-correlates-of-radiotherapy-omission-in-a-population-based-sample-of-older-women-with-favorable-prognosis-breast-cancer
#4
Dean A Shumway, Kent A Griffith, Sarah T Hawley, Lauren P Wallner, Kevin C Ward, Ann S Hamilton, Monica Morrow, Steven J Katz, Reshma Jagsi
BACKGROUND: The omission of radiotherapy (RT) after lumpectomy is a reasonable option for many older women with favorable-prognosis breast cancer. In the current study, we sought to evaluate patient perspectives regarding decision making about RT. METHODS: Women aged 65 to 79 years with AJCC 7th edition stage I and II breast cancer who were reported to the Georgia and Los Angeles County Surveillance, Epidemiology, and End Results registries were surveyed (response rate, 70%) regarding RT decisions, the rationale for omitting RT, decision-making values, and understanding of disease recurrence risk...
April 18, 2018: Cancer
https://www.readbyqxmd.com/read/29661779/report-from-the-swog-radiation-oncology-committee-research-objectives-workshop-2017
#5
Paul Okunieff, Katherine Casey-Sawicki, Natalie A Lockney, Bradford S Hoppe, Heiko Enderling, Chelsea C Pinnix, James W Welsh, Sunil Krishnan, Greg Yothers, J Martin Brown, Susan J Knox, Robert G Bristow, Paul T Spellman, Timur Mitin, Nima Nabavizadeh, Jerry Jaboin, H Charles Manning, Felix Y Feng, Susan M Galbraith, Abhishek A Solanki, Matthew M Harkenrider, Richard Tuli, Roy H Decker, Steven E Finkelstein, Charles C Hsu, Chul S Ha, Reshma Jagsi, Dean Shumway, Megan Daly, Tony J C Wang, Thomas J FitzGerald, Fran Laurie, David T Marshall, David Raben, Louis S Constine, Charles R Thomas, Lisa A Kachnic
Experimental Design: Results: Conclusions.
April 16, 2018: Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
https://www.readbyqxmd.com/read/29558281/concurrent-veliparib-with-chest-wall-and-nodal-radiotherapy-in-patients-with-inflammatory-or-locoregionally-recurrent-breast-cancer-the-tbcrc-024-phase-i-multicenter-study
#6
Reshma Jagsi, Kent A Griffith, Jennifer R Bellon, Wendy A Woodward, Janet K Horton, Alice Ho, Felix Y Feng, Corey Speers, Beth Overmoyer, Michael Sabel, Anne F Schott, Lori Pierce
Purpose Locoregional control for inflammatory breast cancers and chest wall recurrences is suboptimal, which has motivated interest in radiosensitization to intensify therapy. Preclinical studies have suggested a favorable therapeutic index when poly (ADP-ribose) polymerase inhibitors are used as radiosensitizers; clinical investigation is necessary to establish appropriate dosing and confirm safety. Patients and Methods We conducted a multi-institutional phase I study of veliparib and concurrent radiotherapy (RT) to the chest wall and regional lymph nodes in 30 patients with inflammatory or locally recurrent breast cancer after complete surgical resection...
March 20, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/29554690/an-innovative-program-to-support-gender-equity-and-success-in-academic-medicine-early-experiences-from-the-doris-duke-charitable-foundation-s-fund-to-retain-clinical-scientists
#7
Reshma Jagsi, Rochelle D Jones, Kent A Griffith, Kathleen T Brady, Ann J Brown, Randal D Davis, Amelia F Drake, Daniel Ford, Victoria J Fraser, Katherine E Hartmann, Judith S Hochman, Susan Girdler, Anne M Libby, Christina Mangurian, Judith G Regensteiner, Kimberly Yonkers, Sindy Escobar-Alvarez, Elizabeth R Myers
No abstract text is available yet for this article.
March 20, 2018: Annals of Internal Medicine
https://www.readbyqxmd.com/read/29545124/radiation-therapy-for-the-whole-breast-executive-summary-of-an-american-society-for-radiation-oncology-astro-evidence-based-guideline
#8
Benjamin D Smith, Jennifer R Bellon, Rachel Blitzblau, Gary Freedman, Bruce Haffty, Carol Hahn, Francine Halberg, Karen Hoffman, Kathleen Horst, Jean Moran, Caroline Patton, Jane Perlmutter, Laura Warren, Timothy Whelan, Jean L Wright, Reshma Jagsi
INTRODUCTION: The purpose of this guideline is to offer recommendations on fractionation for whole breast irradiation (WBI) with or without a tumor bed boost and guidance on treatment planning and delivery. METHODS AND MATERIALS: The American Society for Radiation Oncology (ASTRO) convened a task force to address 5 key questions focused on dose-fractionation for WBI, indications and dose-fractionation for tumor bed boost, and treatment planning techniques for WBI and tumor bed boost...
March 8, 2018: Practical Radiation Oncology
https://www.readbyqxmd.com/read/29528794/gaps-in-receipt-of-clinically-indicated-genetic-counseling-after-diagnosis-of-breast-cancer
#9
Steven J Katz, Kevin C Ward, Ann S Hamilton, M Chandler Mcleod, Lauren P Wallner, Monica Morrow, Reshma Jagsi, Sarah T Hawley, Allison W Kurian
Purpose Little is known about the extent to which genetic counseling is integrated into community practices for patients newly diagnosed with breast cancer. We examined the receipt of clinically indicated genetic counseling in these patients. Patients and Methods We surveyed 5,080 patients between the ages of 20 and 79 years, diagnosed from July 2013 to August 2015 with early-stage breast cancer and reported to the SEER registries of Georgia and Los Angeles County. Surveys were linked to SEER clinical data and genetic test results...
April 20, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/29485067/long-term-patient-reported-outcomes-in-older-breast-cancer-survivors-a-population-based-survey-study
#10
Cameron W Swanick, Xiudong Lei, Ying Xu, Yu Shen, Nathan A Goodwin, Grace L Smith, Sharon H Giordano, Kelly K Hunt, Reshma Jagsi, Simona F Shaitelman, Susan K Peterson, Benjamin D Smith
PURPOSE: For older women with breast cancer, local therapy options may include lumpectomy plus whole-breast irradiation (Lump + WBI), lumpectomy plus brachytherapy (Lump + Brachy), lumpectomy alone (Lump alone), mastectomy without radiation therapy (Mast alone), and mastectomy plus radiation therapy (Mast + RT). We surveyed a population-based cohort of older breast cancer survivors to assess the association of local therapy with long-term quality-of-life outcomes. METHODS AND MATERIALS: We used nationally comprehensive Medicare claims to identify women aged ≥67 years in whom nonmetastatic breast cancer was diagnosed in 2009, who were treated with 1 of the 5 aforementioned treatment options, and who were still alive in 2015...
March 15, 2018: International Journal of Radiation Oncology, Biology, Physics
https://www.readbyqxmd.com/read/29477292/qualitative-assessment-of-academic-radiation-oncology-department-chairs-insights-on-diversity-equity-and-inclusion-progress-challenges-and-future-aspirations
#11
Rochelle D Jones, Christina H Chapman, Emma B Holliday, Nafisha Lalani, Emily Wilson, James A Bonner, Benjamin Movsas, Shalom Kalnicki, Silvia C Formenti, Charles R Thomas, Stephen M Hahn, Fei-Fei Liu, Reshma Jagsi
PURPOSE: A lack of diversity has been observed in radiation oncology (RO), with women and certain racial/ethnic groups underrepresented as trainees, faculty, and practicing physicians. We sought to gain a nuanced understanding of how to best promote diversity, equity, and inclusion (DEI) based on the insights of RO department chairs, with particular attention given to the experiences of the few women and underrepresented minorities (URMs) in these influential positions. METHODS AND MATERIALS: From March to June 2016, we conducted telephone interviews with 24 RO department chairs (of 27 invited)...
May 1, 2018: International Journal of Radiation Oncology, Biology, Physics
https://www.readbyqxmd.com/read/29470568/reducing-overtreatment-of-cancer-with-precision-medicine-just-what-the-doctor-ordered
#12
Steven J Katz, Reshma Jagsi, Monica Morrow
No abstract text is available yet for this article.
March 20, 2018: JAMA: the Journal of the American Medical Association
https://www.readbyqxmd.com/read/29439886/patient-experiences-and-clinician-views-on-the-role-of-radiation-therapy-for-ductal-carcinoma-in-situ
#13
Dean A Shumway, Chandler M McLeod, Monica Morrow, Yun Li, Allison W Kurian, Aaron Sabolch, Ann S Hamilton, Kevin C Ward, Steven J Katz, Sarah T Hawley, Reshma Jagsi
PURPOSE: To evaluate patient experiences with decisions regarding radiation therapy (RT) for ductal carcinoma in situ (DCIS), and to assess clinician views on the role of RT for DCIS with favorable features in the present era. METHODS AND MATERIALS: A sample of women with newly diagnosed breast cancer from the population-based Georgia and Los Angeles County Surveillance, Epidemiology, and End Results (SEER) registries were sent surveys approximately 2 months after undergoing breast-conserving surgery (BCS), with a 70% response rate...
April 1, 2018: International Journal of Radiation Oncology, Biology, Physics
https://www.readbyqxmd.com/read/29364772/improving-breast-cancer-surgical-treatment-decision-making-the-icandecide-randomized-clinical-trial
#14
Sarah T Hawley, Yun Li, Lawrence C An, Kenneth Resnicow, Nancy K Janz, Michael S Sabel, Kevin C Ward, Angela Fagerlin, Monica Morrow, Reshma Jagsi, Timothy P Hofer, Steven J Katz
Purpose This study was conducted to determine the effect of iCanDecide, an interactive and tailored breast cancer treatment decision tool, on the rate of high-quality patient decisions-both informed and values concordant-regarding locoregional breast cancer treatment and on patient appraisal of decision making. Methods We conducted a randomized clinical trial of newly diagnosed patients with early-stage breast cancer making locoregional treatment decisions. From 22 surgical practices, 537 patients were recruited and randomly assigned online to the iCanDecide interactive and tailored Web site (intervention) or the iCanDecide static Web site (control)...
March 1, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/29237009/recent-trends-in-chemotherapy-use-and-oncologists-treatment-recommendations-for-early-stage-breast-cancer
#15
Allison W Kurian, Irina Bondarenko, Reshma Jagsi, Christopher R Friese, M Chandler McLeod, Sarah T Hawley, Ann S Hamilton, Kevin C Ward, Timothy P Hofer, Steven J Katz
Background: There is growing concern about overtreatment of breast cancer as outcomes have improved over time. However, little is known about how chemotherapy use and oncologists' recommendations have changed in recent years. Methods: We surveyed 5080 women (70% response rate) diagnosed with breast cancer between 2013 and 2015 and accrued through two Surveillance, Epidemiology, and End Results registries (Georgia and Los Angeles) about chemotherapy receipt and their oncologists' chemotherapy recommendations...
December 11, 2017: Journal of the National Cancer Institute
https://www.readbyqxmd.com/read/29236567/sexual-harassment-in-medicine-metoo
#16
Reshma Jagsi
The news is filled with stories of celebrities who have engaged in egregious sexual misconduct. A recent poll suggested that more than half of U.S. women have experienced "unwanted and inappropriate sexual advances" at some point in their lives. Because I led a study of workplace sexual harassment..
December 13, 2017: New England Journal of Medicine
https://www.readbyqxmd.com/read/29152598/study-protocol-a-randomized-controlled-trial-of-a-comprehensive-breast-cancer-treatment-patient-decision-tool-icandecide
#17
Sarah T Hawley, Yun Li, L Alexandra Jeanpierre, Stefanie Goodell, Reshma Jagsi, Kevin C Ward, Michael S Sabel, Steven J Katz
Background: Patients newly diagnosed with breast cancer face a series of complex decisions regarding locoregional and systemic treatment. There is a need to improve the quality of locoregional and systemic decisions for breast cancer patients, and to help patients understand the role of evaluative tests in this decision process. We are now conducting a randomized controlled trial (RCT) of an online decision tool-called iCanDecide, which we expect will help patients with these difficult decisions...
March 2017: Contemporary Clinical Trials Communications
https://www.readbyqxmd.com/read/29116986/it-is-time-for-zero-tolerance-for-sexual-harassment-in-academic-medicine
#18
Carol K Bates, Reshma Jagsi, Lynn K Gordon, Elizabeth Travis, Archana Chatterjee, Marin Gillis, Olivia Means, Linda Chaudron, Rebecca Ganetzky, Martha Gulati, Barbara Fivush, Poonam Sharma, Amelia Grover, Diana Lautenberger, Terence R Flotte
While more women are in leadership positions in academic medicine now than ever before in U.S. history, evidence from recent surveys of women and graduating medical students demonstrates that sexual harassment continues in academic health centers. Academic medicine's ability to change its culture is hampered by victims' fear of reporting episodes of harassment, which is largely due to fear of retaliation. In this Perspective, the authors describe efforts in scientific societies to address the issue of sexual harassment and to begin to establish safe environments at national meetings...
February 2018: Academic Medicine: Journal of the Association of American Medical Colleges
https://www.readbyqxmd.com/read/29106887/patterns-of-treatment-and-outcomes-for-definitive-therapy-of-early-stage-non-small-cell-lung-cancer
#19
Nirav S Kapadia, Luca F Valle, Julie A George, Reshma Jagsi, Thomas A D'Amico, Elisabeth U Dexter, Fawn D Vigneau, Feng Ming Kong
BACKGROUND: Definitive surgical and radiation therapy (RT) treatments are evolving rapidly for stage I non-small cell lung cancer (NSCLC). We hypothesized that utilization of definitive therapies increased between 2000 and 2010 and that survival improved for stage I NSCLC patients over the same time period. Secondary objectives were determining trends in patterns of care and predictors of utilization. METHODS: Population-based, observational, comparative effectiveness study used Surveillance, Epidemiology, and End Results-18 data from 2000 to 2010...
December 2017: Annals of Thoracic Surgery
https://www.readbyqxmd.com/read/29035643/role-of-bone-modifying-agents-in-metastatic-breast-cancer-an-american-society-of-clinical-oncology-cancer-care-ontario-focused-guideline-update
#20
Catherine Van Poznak, Mark R Somerfield, William E Barlow, J Sybil Biermann, Linda D Bosserman, Mark J Clemons, Sukhbinder K Dhesy-Thind, Melissa S Dillmon, Andrea Eisen, Elizabeth S Frank, Reshma Jagsi, Rachel Jimenez, Richard L Theriault, Theodore A Vandenberg, Gary C Yee, Beverly Moy
Purpose To update, in collaboration with Cancer Care Ontario (CCO), key recommendations of the American Society of Clinical Oncology (ASCO) guideline on the role of bone-modifying agents (BMAs) in metastatic breast cancer. This focused update addressed the new data on intervals between dosing and the role of BMAs in control of bone pain. Methods A joint ASCO-CCO Update Committee conducted targeted systematic literature reviews to identify relevant studies. Results The Update Committee reviewed three phase III noninferiority trials of dosing intervals, one systematic review and meta-analysis of studies of de-escalation of BMAs, and two randomized trials of BMAs in control of pain secondary to bone metastases...
December 10, 2017: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
keyword
keyword
27596
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"